Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Maryland Healthcare Reporter.
Press releases published on July 3, 2025
Remote Pharmacy Releases 2025 Availability Update on GLP-1 Weight Loss Solutions and Consumer Interest in Semaglutide & Tirzepatide
GlobeNewswire
·
July 3, 2025
Bowling Green, July 03, 2025 (GLOBE NEWSWIRE) -- Section 1 – Introduction In 2025, the discourse surrounding prescription weight loss treatments is gaining momentum, fueled by increasing public awareness of GLP-1 receptor agonists, such as semaglutide and …
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
July 3, 2025
BEDFORD, Mass., July 03, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the osteoarthritis pain management and regenerative solutions spaces focused on early intervention orthopedics, today announced that on July 1, …
Sienna Announces Second Quarter 2025 Results Release Date and Conference Call
GlobeNewswire
·
July 3, 2025
MARKHAM, Ontario, July 03, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) announced that it will report its 2025 second quarter results after market close on Tuesday, August 12, 2025. Nitin Jain, President and …
Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025
GlobeNewswire
·
July 3, 2025
SOUTH JORDAN, Utah, July 03, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended June 30, …
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
July 3, 2025
BRISBANE, Calif., July 03, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today announced the granting of inducement awards …
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
July 3, 2025
WESTLAKE VILLAGE, Calif., July 03, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today reported the grant of an …
Monte Rosa Announces Publication in Science of Key Insights that Enable Next Generation Molecular Glue Degrader Medicines
GlobeNewswire
·
July 3, 2025
BOSTON, July 03, 2025 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced the publication of groundbreaking new discoveries …
2024 Packaging Research Review: Trends That Will Shape the Future
GlobeNewswire
·
July 3, 2025
Boston, July 03, 2025 (GLOBE NEWSWIRE) -- BCC Research announces the release of its “2024 Packaging Research Review” highlighting significant growth and advances in the sustainable packaging, healthcare packaging, and sustainable plastic packaging markets. …
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
July 3, 2025
DALLAS, July 03, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the …
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
July 3, 2025
SAN DIEGO, July 03, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to …
Mdxhealth Appoints Michael Holder to Board of Directors and Announces Management Change
GlobeNewswire
·
July 3, 2025
IRVINE, CA, and HERSTAL, BELGIUM – July 3, 2025 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a leading precision diagnostics company, today announced the appointment of Michael Holder to its Board of Directors as the Chair …
Complicated Urinary Tract Infections Market Set to Experience Stunning Growth During the Forecast Period (2025–2034) | DelveInsight
GlobeNewswire
·
July 3, 2025
New York, USA, July 03, 2025 (GLOBE NEWSWIRE) -- Complicated Urinary Tract Infections Market Set to Experience Stunning Growth During the Forecast Period (2025–2034) | DelveInsight The growth of the complicated urinary tract infections market is expected …
MESA LABS DECLARES QUARTERLY DIVIDEND
GlobeNewswire
·
July 3, 2025
LAKEWOOD, Colo., July 03, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The …
CapsoVision Announces Closing of Initial Public Offering
GlobeNewswire
·
July 3, 2025
SARATOGA, Calif., July 03, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company that develops advanced imaging and artificial intelligence (“AI”) technologies that are deployed in its capsule endoscopy …
AAMI Aligns With National Academy of Medicine AI Code of Conduct
GlobeNewswire
·
July 3, 2025
Arlington, VA, July 03, 2025 (GLOBE NEWSWIRE) -- The Association for the Advancement of Medical Instrumentation (AAMI) today announces its alignment with the National Academy of Medicine’s (NAM) recently published AI Code of Conduct (AICC). AAMI intends to …
Robotic Surgery Is No Longer the Future—It's the Revenue Engine of Healthcare | MarketsandMarkets™.
GlobeNewswire
·
July 3, 2025
Delray Beach, FL, July 03, 2025 (GLOBE NEWSWIRE) -- What’s powering a $33.8 billion opportunity? The robotic surgery market is on a fast lane, expected to surge from USD 16.0 billion in 2024 to USD 33.8 billion by 2029, at a robust CAGR of 16.1%. This …
PetMed Express Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K
GlobeNewswire
·
July 3, 2025
DELRAY BEACH, Fla., July 03, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (“PetMeds®”) (NASDAQ: PETS) received on July 2, 2025, an expected notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, as a result of not having timely …
Only Transparency and Accountability Can Save CERN: Stop Billions in Waste, Unlock Life-Saving Innovations
GlobeNewswire
·
July 3, 2025
DALLAS, July 03, 2025 (GLOBE NEWSWIRE) -- The Crosetto Foundation for the Reduction of Cancer Deaths, an accredited nonprofit, issues an “urgent appeal to Members of the European Parliament and national parliaments: freeze funding for CERN’s Phase 2 …
BioAtla Presents Data from Ongoing Dose Escalation of BA3182, Dual-Conditionally Binding EpCAM x CD3 Bispecific T-cell Engager, in Patients with Treatment Refractory Metastatic Adenocarcinoma at the 2025 European Society for Medical Oncology (ESMO)…
GlobeNewswire
·
July 3, 2025
Adverse events were generally low-grade, transient, and readily manageable Achieved preliminary evidence of prolonged tumor control and tumor reductions in heavily pretreated adenocarcinoma patients Dose escalation now continuing at 1.2 mg weekly by …
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
July 3, 2025
SAN DIEGO, July 03, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that on July …